Hopman Mark
Reporting owner on Forms 3, 4 and 5, CIK 2048497.
Hopman Mark reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Beta Bionics, Inc. CIK 1674632 | officer (Chief Commercial Officer) | 1 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Beta Bionics, Inc. Common Stock | 2026-10-01 | S sold | -370 | $18.96 | 56,109 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002048497-26-000018 | Beta Bionics, Inc. | 2026-10-05 |